Analyst firms · Argus Research · HOLX
Argus Research HOLX price target and rating history
Hologic Inc. (HOLX) · Health Care
Argus Research rates Hologic Inc. (HOLX) Hold with a $80 price target, as of its latest action on Jan 12, 2026. It has published 3 rating actions on HOLX since March 2025, including 1 upgrade and 2 downgrades.
- Current rating
- Hold
- Price target
- $80
- Median target, all firms
- Too few
- Actions on HOLX
- 3
Every Argus Research rating on HOLX
- Jan 12, 2026
- Aug 18, 2025
- Mar 3, 2025
How other firms rate HOLX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Argus Research | Hold | Jan 12, 2026 | |
| Evercore ISI | In-line | $78 | Jan 5, 2026 |
| BNP Paribas Exane | Neutral | $79 | Nov 21, 2025 |
Questions about Argus Research and HOLX
- What is Argus Research's price target for HOLX?
- Argus Research's latest stated price target for Hologic Inc. (HOLX) is $80, from its action on Aug 18, 2025.
- What is Argus Research's rating on HOLX?
- Argus Research rates HOLX Hold, a neutral rating, as of Jan 12, 2026.
- When did Argus Research last change its view on HOLX?
- On Jan 12, 2026, Argus Research downgrades to Hold from Buy.
More HOLX rating histories
All Argus Research ratingsHOLX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.